Higher Incidence of SIADH During Induction Chemotherapy in Pediatric Acute Lymphoblastic Leukemia: An Indian Experience

被引:0
|
作者
Seetharam, S. [1 ]
Thankamony, P. [1 ]
Gopakumar, K. G. [1 ]
机构
[1] Reg Canc Ctr, Pediat Oncol, Thiruvananthapuram, Kerala, India
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO-263
引用
收藏
页码:S540 / S541
页数:2
相关论文
共 50 条
  • [21] Acute complications observed during intensive chemotherapy in pediatric patients with acute lymphoblastic leukemia: Single-center experience
    Yildirim, Ulku Miray
    Tekkesin, Funda
    Koc, Begum Sirin
    Aydogdu, Selime
    Asarcikli, Fikret
    Kilic, Suar Caki
    NORTHERN CLINICS OF ISTANBUL, 2023, 10 (04) : 458 - 469
  • [22] Toxicity of dexamethasone (DEX) vs prednisone (PRED) during induction chemotherapy for pediatric acute lymphoblastic leukemia (ALL)
    Belgaumi, AF
    Al-Bakrah, M
    Al-Mahr, M
    Al-Jefri, A
    Al-Musa, AR
    Saleh, M
    Salim, MF
    OSman, M
    Osman, L
    El-Solh, H
    PEDIATRIC RESEARCH, 2002, 51 (04) : 234A - 234A
  • [23] Factors Associated with Prolonged Hospital Stay during Induction Chemotherapy for High Risk Pediatric Acute Lymphoblastic Leukemia
    Warrick, Kasper
    Althouse, Sandra K.
    Rahrig, April
    Joy, Rupenthal
    Batra, Sandeep
    BLOOD, 2017, 130
  • [24] Non-alcoholic steatohepatitis induced by induction chemotherapy for pediatric acute lymphoblastic leukemia
    Yamamoto, Masaki
    Hori, Tsukasa
    Igarashi, Keita
    Iesato, Kotoe
    Saito, Makoto
    Miyanishi, Koji
    Kikuchi, Noriaki
    Fujita, Hiromi
    Tsutsumi, Hiroyuki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 107 (04) : 390 - 391
  • [25] Non-alcoholic steatohepatitis induced by induction chemotherapy for pediatric acute lymphoblastic leukemia
    Masaki Yamamoto
    Tsukasa Hori
    Keita Igarashi
    Kotoe Iesato
    Makoto Saito
    Koji Miyanishi
    Noriaki Kikuchi
    Hiromi Fujita
    Hiroyuki Tsutsumi
    International Journal of Hematology, 2018, 107 : 390 - 391
  • [26] Nephrotic syndrome developing during induction chemotherapy for childhood acute lymphoblastic leukemia
    Chanel Prestidge
    Shahrad Rod Rassekh
    Douglas G. Matsell
    Clinical and Experimental Nephrology, 2011, 15 : 410 - 413
  • [27] ‘Primary cutaneous mucormycosis during induction chemotherapy in a child with acute lymphoblastic leukemia’
    Jhuma Sankar
    Sasi Arun
    Mari Jeeva Sankar
    Rachna Seth
    Vasantha Thavraj
    Sushil Kumar Kabra
    M Vasantha
    The Indian Journal of Pediatrics, 2009, 76 : 1161 - 1163
  • [28] Coagulation disorders in patients with acute lymphoblastic leukemia (ALL) during induction chemotherapy
    Chojnowski, K
    Wawrzyniak, E
    Trelinski, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 131 - 131
  • [29] COMPLICATIONS BY CENTRAL LINE TYPE DURING INDUCTION CHEMOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA
    Degroote, Nicholas
    Joshi, Vivek
    West, Zachary
    Bathina, Neil
    Castellino, Sharon
    Miller, Tamara
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [30] Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia
    Sulis, M. L.
    Blonquist, T. M.
    Stevenson, K. E.
    Hunt, S. K.
    Kay-Green, S.
    Athale, U. H.
    Clavell, L. A.
    Cole, P. D.
    Kelly, K. M.
    Laverdiere, C.
    Leclerc, J. M.
    Michon, B.
    Schorin, M. A.
    Welch, J. G.
    Neuberg, D. S.
    Sallan, S. E.
    Silverman, L. B.
    PEDIATRIC BLOOD & CANCER, 2018, 65 (05)